REMOVAL ESTIMATE 22 SUBSTANCE , INCLUDE MANCOZEB AND OPUS , WILL AFFECT PRODUCT AVAILABILITY .

the removal of an estimated 22 substances , including mancozeb and opus , will affect product availability .
